CLINICAL_TRIALS
research
· 2025-05-30
Clinical Trial Update: Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating induction chemoimmunotherapy followed by chemoradiotherapy (with possible surgery) for esophageal cancer; the study is current…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer, Immunotherapy | Phase 2 | Status: RECRUITING